Autor: "Thompson JA" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Combining immune checkpoint inhibition plus tyrosine kinase inhibition as first and subsequent treatments for metastatic renal cell carcinoma.
Autorzy:: Yang Y; Genitourinary Oncology Section, Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital, Columbus, Ohio, USA.
Psutka SP; Department of Urology, University of Washington School of Medicine, Seattle, Washington, USA.
Parikh AB; Genitourinary Oncology Section, Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital, Columbus, Ohio, USA.
Li M; Genitourinary Oncology Section, Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital, Columbus, Ohio, USA.
Collier K; Genitourinary Oncology Section, Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital, Columbus, Ohio, USA.
Miah A; Genitourinary Oncology Section, Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital, Columbus, Ohio, USA.
Mori SV; Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
Hinkley M; Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
Tykodi SS; Division of Medical Oncology, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington, USA.
Hall E; Division of Medical Oncology, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington, USA.
Thompson JA; Division of Medical Oncology, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington, USA.
Yin M; Genitourinary Oncology Section, Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital, Columbus, Ohio, USA.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2022 Aug; Vol. 11 (16), pp. 3106-3114. Date of Electronic Publication: 2022 Mar 18.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Carcinoma, Renal Cell*/drug therapy
Carcinoma, Renal Cell*/pathology
Immune Checkpoint Inhibitors*/therapeutic use
Kidney Neoplasms*/drug therapy
Kidney Neoplasms*/pathology
Protein-Tyrosine Kinases*/antagonists & inhibitors
Adult ; Humans ; Nivolumab/therapeutic use ; Retrospective Studies